$0.88
+0.01 (+0.94%)
Open$0.86
Previous Close$0.87
Day High$0.90
Day Low$0.84
52W High$1.57
52W Low$0.38
Volume—
Avg Volume142.4K
Market Cap43.96M
P/E Ratio—
EPS$-0.36
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,875.1% upside
Current
$0.88
$0.88
Target
$26.13
$26.13
$16.33
$26.13 avg
$37.99
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 35.0K | 139.6K | 15.27M |
| Net Income | -16,861,785 | -60,460,583 | 4.70M |
| Profit Margin | -51,035.7% | -48,483.9% | 30.8% |
| EBITDA | -17,462,383 | -66,092,684 | 6.30M |
| Free Cash Flow | — | — | 4.04M |
| Rev Growth | -74.9% | -74.9% | -3.4% |
| Debt/Equity | — | — | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |